terazosin

Generic: terazosin

Labeler: bionpharma inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin
Labeler bionpharma inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 1 mg/1

Manufacturer
Bionpharma Inc.

Identifiers & Regulatory

Product NDC 69452-330
Product ID 69452-330_29b9921b-6884-e5bb-e063-6394a90aecf6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075667
Listing Expiration 2026-12-31
Marketing Start 2024-03-11

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69452330
Hyphenated Format 69452-330

Supplemental Identifiers

RxCUI
260376 313215 313217 313219
UPC
0369452331323 0369452330326 0369452333327 0369452332320
UNII
D32S14F082

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin (source: ndc)
Application Number ANDA075667 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (69452-330-20)
  • 1000 CAPSULE in 1 BOTTLE (69452-330-32)
source: ndc

Packages (2)

69452-330-20 100 CAPSULE in 1 BOTTLE (69452-330-20) 69452-330-32 1000 CAPSULE in 1 BOTTLE (69452-330-32)

Ingredients (1)

terazosin hydrochloride (1 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "29b9921b-6884-e5bb-e063-6394a90aecf6", "openfda": {"upc": ["0369452331323", "0369452330326", "0369452333327", "0369452332320"], "unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["130c84dc-b598-660f-e063-6294a90a8e46"], "manufacturer_name": ["Bionpharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69452-330-20)", "package_ndc": "69452-330-20", "marketing_start_date": "20240311"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (69452-330-32)", "package_ndc": "69452-330-32", "marketing_start_date": "20241220"}], "brand_name": "Terazosin", "product_id": "69452-330_29b9921b-6884-e5bb-e063-6394a90aecf6", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "69452-330", "generic_name": "Terazosin", "labeler_name": "Bionpharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "1 mg/1"}], "application_number": "ANDA075667", "marketing_category": "ANDA", "marketing_start_date": "20240311", "listing_expiration_date": "20261231"}